X0508 4 2025-03-05 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0002025621 Shields Matthew C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL false true false false EVP, Global Operations false Restricted Share Units 2025-03-05 4 A false 69182 0 A Ordinary Shares 69182 69182 D Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. /s/ Dov Bergwerk as attorney-in-fact for Matthew Shields 2025-03-07